AdvanCell Isotopes Pty Ltd
0 followers
‌
AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
Industries
+1
Employees
Links
Org chart
Andrew Adamovich
Chief Executive Officer
Andrew Adamovich
Collapse
Julian F. Kelly
Chief Scientist (Nuclear & Chemical)
Kevin Kuan
SVP Technical Operations
Nicolò Canever
Materials Development Manager
Sheridan Martin
Facilities Manager And Head Radiation Safety Officer
Simon Puttick
CSO/COO
Thomas Kryza
Head Of Preclinical Development
Vanessa Worsfold
Head Of Quality And Head Of Marketing
Sheruna Naidoo
Head Of Quality And Regulatory Affairs
Michael Tung
Chief Financial Officer
